Last reviewed · How we verify
NCT06012981
Psychological Treatment in Psychiatric Inpatient Care
NA trial testing ACT in Compulsory Psychiatric Care Act in 1 participant. Terminated before completion.
15 November 2023
Quick facts
| Lead sponsor | Uppsala University |
|---|---|
| Phase | NA |
| Status | Terminated |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 1 |
| Start date | 1 September 2023 |
| Primary completion | 15 November 2023 |
| Estimated completion | 15 November 2023 |
| Sites | 1 location across Sweden |
Drugs / interventions tested
- ACT — full drug profile →
Conditions studied
- Compulsory Psychiatric Care Act — all drugs for Compulsory Psychiatric Care Act →
- Psychosis — all drugs for Psychosis →
- Acceptance & Commitment Therapy — all drugs for Acceptance & Commitment Therapy →
- Psychiatric Hospitalization — all drugs for Psychiatric Hospitalization →
Sponsor
Uppsala University
Who can join
18 and older, any sex, with Compulsory Psychiatric Care Act or Psychosis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to investigate the effect of a brief psychotherapeutic treatment intervention based on ACT, aimed specifically at the vulnerable group of patients in psychiatric 24-hour care treated according to LPT. The study aims to investigate whether a brief number of therapeutic sessions according to ACT during inpatient care produce positive effects on personally relevant life areas for a diagnostically mixed group of patients in a psychiatric intensive care unit.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06012981
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of ACT
Trials testing the same drug.
- NCT07426367 — Internet-Delivered ACT Targeting Emotional Distress and Chronic Pain · NA · not yet recruiting
- NCT07272421 — Comparing ACT, Recuperation, and ACT Plus Vocational Support for Clinical Burnout · NA · not yet recruiting
- NCT06617663 — Online Therapy Youth, Equivalent to Treatment As Usual? · NA · recruiting
- NCT06109493 — Effects of an ACT-based Psychological Treatment in Patients With Chronic Kidney Disease · NA · recruiting
- NCT07501130 — Feasibility of Telephone-based Acceptance and Commitment Therapy in Hong Kong Chinese Young Adults With Alcohol Use Diso · NA · active not recruiting
Other Uppsala University trials
Trials by the same sponsor.
- NCT07517185 — The HIt HArd and hiT Early in Multiple Sclerosis Trial · Phase 2 · not yet recruiting
- NCT07351149 — Postoperative Acute Kidney Injury in Children Undergoing Major Non-cardiac Surgery · recruiting
- NCT07461636 — Robotic-Assisted Pedicle Screw Placement in Spine Surgery · recruiting
- NCT07273409 — Pancreatic Neuroendocrine Tumour - Optimal Surgical Debulking or Not · NA · recruiting
- NCT07352683 — Open TAP-block in Pediatric Abdominal Surgery · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06012981 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Uppsala University
- Last refreshed: 20 December 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06012981.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing